Measles Outbreaks and Implications for HCT and CAR T-Cell Therapy Patients

Join us for an expert-led session on Thursday, May 1st at 11 a.m. CDT exploring the rising concern of measles outbreaks and their unique risks for patients undergoing Hematopoietic Cell Transplantation (HCT) and CAR T-cell therapies. This webinar will cover clinical implications, prevention strategies, and guidance for patient management in the context of immunocompromised populations. Attendees will gain insights from current data, vaccination strategies, and best practices for infection control and post-exposure management.

Intended Audience: Transplant physicians, infectious disease specialists, oncologists, pharmacists, and healthcare providers involved in immunocompromised patient care.

Panelists: 

Mini Kamboj, MD, Memorial Sloan Kettering Cancer Center

Steven Pergam, MD, MPH, Fred Hutch Cancer Center

Alpana Waghmare, MD, University of Washington School of Medicine